Non-Invasive Deep Brain Neuromodulation for Smoking Cessation
Key facts
- Who runs it
- The University of Texas Health Science Center, Houston
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 13 Apr 2026
- Expected to end
- 30 Nov 2030
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Low intensity focused ultrasound with active stimulations
- low intensity focused ultrasound with sham stimulations
- Record updated
- 23 June 2026
Who can take part
- Age
- 20 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Must be a smoker for 5 or more years and within 20 to 60 years of age
- Must not meet exclusion criteria for MRI scanning (e.g., non-fixed magnetizable objects)
- Must not have ongoing unstable medical, neurological or psychiatric illness as determined by a combination of history, medical record, and/or examination
- Must be a current smoker with average of 5 cigarettes or more a day for the last month or longer
- Report 3 or more trials of smoking cessation attempts using nicotine replacement, e-cig, TMS, varenicline or other smoking cessation drugs, psychotherapy or other means
Who cannot take part
- Significant alcohol or other drug use (substance dependence within the recent months) or positive urine toxicology screen for substance not prescribed other than nicotine or marijuana dependence
- Cannot refrain from using alcohol and/or marijuana 24 hours or more prior to experiments
- Taking > 400 mg clozapine/day and not on anti-seizure medication(s) with sufficient dose
- Failed TMS screening questionnaire
- Woman who is pregnant (child-bearing potential but not on contraceptive and missing menstrual period; or by self-report; or by positive pregnancy test) or has had unprotected sexual intercourse without birth control in the last 4 weeks
- In ongoing smoking cessation treatment, clinical trial, or nicotine replacements (except for the current study)
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 20 and 60 years old?
This trial is currently available in United States.
- The University of Texas Health Science Center at HoustonHouston, United StatesContact: Xiaoming Du, PhDTaking people
About the trial
What the trial wants to find out
This study will develop novel low intensity focused ultrasound (LIFU) therapy to help people to quit cigarette smoking. Smoking is associated with cancers of the lung. Available smoking cessation methods help many to quit. However, for the many who continue to smoke despite the strong desire to quit and after exhausting existing therapeutic approaches, new treatment methods are needed. Without more effective treatment, many will continue to smoke, and our progress on cancer prevention through smoking cessation may decelerate as these associated cancer risks will remain. Brain imaging research has identified specific areas of the brain linked to severe nicotine addiction, but up to now there are no effective ways to directly target most of these deeper brain regions. LIFU is a new and safe method to modulate brain functions that can either inhibit overactive activity or restore normal activity levels. The purpose of this study is to provide a novel ultrasound-based neuromodulation strategy for smoking cessation in people who have difficulty to quit smoking despite numerous serious attempts in their lives. LIFU works by sending acoustic pressure modulating neural activity in the human brain.
The 2 groups in the trial
- Active low intensity focused ultrasound (LIFU)Treatment being tested
Participants in this group will receive active LIFU treatment
Treatment: Low intensity focused ultrasound with active stimulations
- Sham LIFUSham treatment, for comparison
Participants in this group will receive sham LIFU treatment
Treatment: low intensity focused ultrasound with sham stimulations
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07298902, who can take part
- Record updated
- 23 June 2026